Victoria is home to incredible medtech capability and there’s growing momentum to ensure more of it is seen, evaluated and adopted locally.
That’s exactly what the Australian Medtech Manufacturing Alliance (AMMA) is driving: bringing industry and health system leaders closer together to create clearer, more consistent pathways from pilot to purchase.
It’s a full day of connection and collaboration between Australia’s medtech industry and the health system.
We’re proud to showcase an exceptional cohort of locally designed and manufactured medtech innovations including:
🔺 4DMedical Medical’s world-first four-dimensional lung imaging technology
🔺 PolyNovo Limited‘s NovoSorb® technology transforming the management of complex wounds globally.
🔺 Lenexa Medical is combining fabric-based sensors with AI to prevent pressure injuries, a problem costing Australia’s health system over $9 billion annually.
🔺 MX3 Diagnostics delivers real-time, saliva-based hydration testing in seconds, from mining sites to healthcare settings.
Seven of MTPConnect’s Pathway to Market cohort companies including Arelis, Mediklean, Proton Intelligence and Sadleir Laboratories will also take the stage as part of this program’s finale.
The day will feature lightning pitches, keynote speakers from health and procurement leadership, and interactive roundtables designed to move the conversation from pilot to purchase.
If you’re a medtech company, clinician, procurement leader, investor or ecosystem partner, this is your chance to connect and help shape how medtech is evaluated and adopted in Australia.
Join us and be part of “Better Health Made Here.”
Event Details:
⏱️ 7 May 2026, 9am – 4.00pm AEST
📍 Aerial, South Wharf (Melbourne, Victoria)
👉 Register now: https://lnkd.in/gC5ZHPZm